Total Payments
$23,234
2024 Payments
$2,038
Companies
7
Transactions
26
Medicare Patients
493
Medicare Billing
$62,997
Payment Breakdown by Category
Consulting$19,703 (84.8%)
Travel$2,803 (12.1%)
Food & Beverage$727.86 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,703 | 3 | 84.8% |
| Travel and Lodging | $2,803 | 6 | 12.1% |
| Food and Beverage | $727.86 | 17 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals AS | $13,891 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $7,094 | 2 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $2,033 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $98.72 | 1 | $0 (2018) |
| Boston Scientific Corporation | $49.26 | 2 | $0 (2022) |
| Coloplast Corp | $44.24 | 2 | $0 (2023) |
| C. R. Bard, Inc. & Subsidiaries | $23.71 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,038 | 6 | Ferring Pharmaceuticals AS ($1,077) |
| 2023 | $44.24 | 2 | Coloplast Corp ($44.24) |
| 2022 | $20,984 | 15 | Ferring Pharmaceuticals AS ($12,814) |
| 2021 | $25.03 | 1 | BOSTON SCIENTIFIC CORPORATION ($25.03) |
| 2019 | $43.50 | 1 | Merck Sharp & Dohme Corporation ($43.50) |
| 2018 | $98.72 | 1 | Astellas Pharma US Inc ($98.72) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Urology | ||||||
| 12/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Consulting Fee | Cash or cash equivalent | $935.00 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2024 | Ferring Pharmaceuticals AS | ADSTILADRIN (Biological) | Travel and Lodging | In-kind items and services | $654.75 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2024 | Ferring Pharmaceuticals AS | ADSTILADRIN (Biological) | Travel and Lodging | In-kind items and services | $296.46 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2024 | Ferring Pharmaceuticals AS | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $126.00 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2023 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Continence Care | ||||||
| 05/10/2023 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Continence Care | ||||||
| 09/28/2022 | Ferring Pharmaceuticals AS | — | Consulting Fee | Cash or cash equivalent | $11,718.00 | General |
| 09/10/2022 | Ferring Pharmaceuticals AS | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 09/10/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $59.99 | General |
| 09/10/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/10/2022 | Ferring Pharmaceuticals AS | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/10/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 09/10/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 09/10/2022 | Ferring Pharmaceuticals AS | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 09/10/2022 | Ferring Pharmaceuticals AS | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 09/09/2022 | Ferring Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $602.20 | General |
| 09/09/2022 | Ferring Pharmaceuticals AS | — | Travel and Lodging | In-kind items and services | $602.20 | General |
| 09/09/2022 | Ferring Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $323.65 | General |
| 09/09/2022 | Ferring Pharmaceuticals AS | — | Travel and Lodging | In-kind items and services | $323.65 | General |
| 03/01/2022 | Boston Scientific Corporation | AMS 700 CXR RTE Kit (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: AMS 700 CXR RTE Kit_URO | ||||||
| 01/24/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $7,050.00 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2021 | BOSTON SCIENTIFIC CORPORATION | AMS 700 CXR RTE KIT (Device) | Food and Beverage | Cash or cash equivalent | $25.03 | General |
| Category: AMS 700 CXR RTE Kit | ||||||
| 03/01/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $43.50 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 220 | 1,622 | $184,733 | $28,761 |
| 2022 | 6 | 127 | 1,102 | $96,336 | $15,458 |
| 2021 | 7 | 146 | 171 | $104,724 | $18,778 |
Total Patients
493
Total Services
2,895
Medicare Billing
$62,997
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 49 | $22,125 | $4,903 | 22.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 41 | 71 | $70,016 | $4,004 | 5.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 29 | $18,154 | $3,977 | 21.9% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 17 | 46 | $16,066 | $3,240 | 20.2% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 14 | 14 | $18,039 | $3,173 | 17.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $15,195 | $3,157 | 20.8% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 16 | 1,291 | $5,164 | $2,926 | 56.7% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 12 | 13 | $14,569 | $2,192 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $4,665 | $937.04 | 20.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 74 | $740.00 | $252.34 | 34.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 34 | 53 | $46,484 | $3,297 | 7.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 24 | $13,977 | $2,977 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 25 | $10,495 | $2,597 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $10,110 | $2,310 | 22.9% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2022 | 19 | 34 | $11,462 | $2,288 | 20.0% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2022 | 16 | 952 | $3,808 | $1,989 | 52.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 50 | $25,870 | $7,147 | 27.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 35 | $13,475 | $3,370 | 25.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $12,618 | $3,045 | 24.1% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 29 | 35 | $30,865 | $2,216 | 7.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $6,019 | $1,487 | 24.7% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Facility | 2021 | 11 | 11 | $14,817 | $1,292 | 8.7% |
| 74420 | Imaging of urinary tract | Facility | 2021 | 11 | 11 | $1,060 | $220.33 | 20.8% |
About Dr. Vikram Narayan, MD
Dr. Vikram Narayan, MD is a Urology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2013. The National Provider Identifier (NPI) number assigned to this provider is 1336582782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Narayan, MD has received a total of $23,234 in payments from pharmaceutical and medical device companies, with $2,038 received in 2024. These payments were reported across 26 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($19,703).
As a Medicare-enrolled provider, Narayan has provided services to 493 Medicare beneficiaries, totaling 2,895 services with total Medicare billing of $62,997. Data is available for 3 years (2021–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Atlanta, GA
- Active Since 04/15/2013
- Last Updated 07/13/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1336582782
Products in Payments
- KEYTRUDA (Biological) $7,094
- ADSTILADRIN (Biological) $2,015
- SpeediCath (Device) $44.24
- AMS 700 CXR RTE KIT (Device) $25.03
- AMS 700 CXR RTE Kit (Device) $24.23
- Bard Urinary Drainage Bag (Device) $23.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Atlanta
Tariq Hakky, Md, MD
Urology — Payments: $406,788
Urology $406,788
Dr. Matthew Sand, M.d, M.D
Urology — Payments: $146,820
Urology $146,820
Dr. James Bennett, M.d, M.D
Urology — Payments: $63,256
Urology $63,256
Dr. Anthony Barnes, M.d, M.D
Urology — Payments: $59,315
Urology $59,315
Viraj Master, M.d, M.D
Urology — Payments: $33,871
Urology $33,871
Dr. Rajesh Laungani, M.d, M.D
Urology — Payments: $32,044
Urology $32,044